Avilex Pharma

Avilex Pharma develops novel inhibitors of PDZ domain proteins to target a range of unmet medical needs with a lead drug candidate AVLX-144 for the treatment of ischemic stroke.

Contact name:

Kristian Strømgaard


Ole Maaløes Vej 3, 2200 København N, Denmark

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2015 Danskbiotek. All rights reserved.